Holen Sie sich die Stockscreener-App
0.629
42.95%
0.189
Handel nachbörslich:
.58
-0.049
-7.79%
Schlusskurs vom Vortag:
$0.44
Offen:
$0.4279
24-Stunden-Volumen:
2.26M
Relative Volume:
3.06
Marktkapitalisierung:
$35.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+17.55%
1M Leistung:
-13.34%
6M Leistung:
-75.99%
1J Leistung:
-85.90%
1-Tages-Spanne:
$0.4268
$0.645
1-Wochen-Bereich:
$0.41
$0.75
52-Wochen-Spanne:
$0.41
$4.77
Tuhura Biosciences Inc Stock (HURA) Company Profile
Firmenname
Tuhura Biosciences Inc
Sektor
Branche
Telefon
813-875-6600
Adresse
10500 UNIVERSITY CENTER DR., TAMPA
Compare HURA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
0.629 | 24.85M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.92 | 116.41B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.51 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
811.45 | 50.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.76B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
353.92 | 38.40B | 4.98B | 69.60M | 525.67M | 0.5198 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-19 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-11-05 | Eingeleitet | Maxim Group | Buy |
Tuhura Biosciences Inc Aktie (HURA) Neueste Nachrichten
TuHURA Biosciences receives FDA orphan drug designation for melanoma drug By Investing.com - Investing.com South Africa
TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma - MEXC
TuHURA Receives FDA Orphan Drug Designation - intellectia.ai
TuHURA Biosciences receives FDA orphan drug designation for melanoma drug - Investing.com
FDA grants orphan status to TuHURA melanoma therapy IFx-2.0 - stocktitan.net
Quarterly Earnings: What dividend growth rate does TuHURA Biosciences Inc offer2025 Volume Leaders & Trade Opportunity Analysis - baoquankhu1.vn
TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice - TipRanks
TuHURA Biosciences Received Notice of Noncompliance - TradingView
Will TuHURA Biosciences Inc. outperform its industry peers2025 Volume Leaders & Safe Capital Investment Plans - mfd.ru
Risk Recap: How is TuHURA Biosciences Inc managing supply chain issuesJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - baoquankhu1.vn
Breakout Watch: How is TuHURA Biosciences Inc managing supply chain issuesWeekly Profit Summary & Weekly Setup with High ROI Potential - baoquankhu1.vn
TuHURA Biosciences (NASDAQ:HURA) Shares Up 0.5% – Here’s Why - Defense World
MACD Signal: Will TuHURA Biosciences Inc outperform its industry peers2025 Historical Comparison & Verified High Yield Trade Plans - baoquankhu1.vn
Will TuHURA Biosciences Inc. stock gain from lower inflation2025 Investor Takeaways & Expert Curated Trade Setup Alerts - Улправда
Will TuHURA Biosciences Inc. stock benefit from green energy trendsQuarterly Portfolio Report & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is TuHURA Biosciences Inc. stock supported by innovation pipelinePrice Action & Verified Momentum Stock Alerts - ulpravda.ru
HURA: Analyst Reiterates Buy Rating, Lowers Price Target | HURA Stock News - GuruFocus
Risk Hedge: Will TuHURA Biosciences Inc. (PL3) stock attract long term capital inflows - Улправда
Can TuHURA Biosciences Inc. (PL3) stock expand revenue streams2025 Historical Comparison & Weekly High Return Stock Forecasts - ulpravda.ru
Why TuHURA Biosciences Inc. stock is popular among millennialsTake Profit & AI Driven Stock Price Forecasts - ulpravda.ru
Why TuHURA Biosciences Inc. stock could see breakout soonMid Cap Growth Trends & Rapid Capital Gain - ulpravda.ru
TuHURA Biosciences Inc Stock Analysis and ForecastRetail Trading Trends & Enter Your Email to Get Stock Alerts - earlytimes.in
Tuhura Biosciences amends loan agreement, secures full $3M - MSN
Is TuHURA Biosciences Inc PL3 a good long term investmentStop Loss Placement Tips & Big Profit Small Investment - earlytimes.in
What the Latest News Means for ABS Marine Services Limited Stock InvestorsTake Profit Strategies & Free Tremendous Portfolio Expansion - earlytimes.in
TUHURA Biosciences announces $15.6M registered direct offering - MSN
What analysts say about TuHURA Biosciences Inc PL3 stockEvening Star Patterns & Don’t Miss These Undervalued Stocks - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Actinogen Medical (OtherATGGF) and TuHURA Biosciences (HURA) - The Globe and Mail
Does TuHURA Biosciences Inc. stock trade at a discount to peers2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Улправда
Will TuHURA Biosciences Inc. (PL3) stock attract long term capital inflows2025 Technical Patterns & Expert Verified Movement Alerts - Улправда
Volume Summary: Does TuHURA Biosciences Inc. stock trade at a discount to peers2025 Trade Ideas & Free Safe Capital Growth Stock Tips - Улправда
Can TuHURA Biosciences Inc. stock reach $100 price targetPortfolio Update Summary & High Accuracy Trade Signal Alerts - Улправда
Aug Retail: How TuHURA Biosciences Inc. stock compares to industry benchmarksWeekly Profit Recap & Consistent Return Strategy Ideas - Улправда
2026 world cup match preview insights: Will TuHURA Biosciences Inc. stock outperform Nasdaq index2026 world cup usa national team round of 32 key players transition play match prediction guide - ulpravda.ru
How TuHURA Biosciences Inc. stock compares to industry benchmarksTrade Ideas & Consistent Growth Equity Picks - Улправда
Will TuHURA Biosciences Inc. stock deliver shareholder valueTrade Volume Report & Free Expert Approved Momentum Trade Ideas - Улправда
Is TuHURA Biosciences Inc. (PL3) stock a top pick for value investors2025 Trading Recap & Stepwise Trade Signal Implementation - Улправда
Can TuHURA Biosciences Inc. stock sustain free cash flow growth2025 Stock Rankings & Weekly High Potential Stock Alerts - DonanımHaber
Can TuHURA Biosciences Inc. stock weather global recessionWeekly Loss Report & Growth Focused Stock Reports - Улправда
TuHURA Biosciences Earnings Notes - Trefis
Rate Hike: Can TuHURA Biosciences Inc. (PL3) stock expand revenue streamsCEO Change & Weekly Top Gainers Alerts - Улправда
[Form 4] TuHURA Biosciences, Inc./NV Insider Trading Activity - Stock Titan
TuHURA Biosciences, Inc. (HURA) CEO discloses 3.4M option grant terms in filing - Stock Titan
TuHURA Biosciences, Inc. (NASDAQ:HURA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
TuHURA Biosciences, Inc. (NASDAQ:HURA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
TuHURA Biosciences Announces Its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone - 富途牛牛
TuHURA Biosciences announces release of Kintara’s CVR - TipRanks
Finanzdaten der Tuhura Biosciences Inc-Aktie (HURA)
Es liegen keine Finanzdaten für Tuhura Biosciences Inc (HURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):